BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28028967)

  • 1. Angiogenesis in CD5-positive Diffuse Large B Cell Lymphoma: A Morphometric Analysis.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Wolińska E; Kulczycka E; Ziarkiewicz-Wróblewska B
    Adv Clin Exp Med; 2016; 25(6):1149-1155. PubMed ID: 28028967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare CD5-positive subgroup of diffuse large B-cell lymphoma - clinical, morphological and immunophenotypic features in Polish patients.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Kulczycka E; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2016; 67(3):235-243. PubMed ID: 28155972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
    Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y
    Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
    Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
    Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.
    Kong SY; Cho EH; Woo HY; Park Q; Ko YH; Kim SH
    J Korean Med Sci; 2004 Dec; 19(6):815-9. PubMed ID: 15608391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).
    Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Am J Clin Pathol; 2009 Mar; 131(3):339-46. PubMed ID: 19228640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization.
    Karnan S; Tagawa H; Suzuki R; Suguro M; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2004 Jan; 39(1):77-81. PubMed ID: 14603444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
    Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
    Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sub-classification of diffuse large B-cell lymphoma by semi-quantification of the CD5 expression with flow cytometric analysis].
    Manabe N; Yamaoka G; Ohnishi H; Arai T; Nakaishi H; Kajikawa T; Kubota Y; Tanaka T; Kitanaka A; Waki M; Kawakami K; Nagai M; Ishida T; Taminato T
    Rinsho Byori; 2002 Sep; 50(9):906-11. PubMed ID: 12386970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression.
    Miyazaki K; Yamaguchi M; Imai H; Kobayashi K; Tamaru S; Kobayashi T; Shiku H; Katayama N
    Int J Hematol; 2015 Aug; 102(2):188-94. PubMed ID: 26009281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
    Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
    Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
    Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R
    Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.
    Thakral B; Medeiros LJ; Desai P; Lin P; Yin CC; Tang G; Khoury JD; Hu S; Xu J; Loghavi S; Hu B; Oki Y; Li S
    Eur J Haematol; 2017 Apr; 98(4):415-421. PubMed ID: 28039906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma.
    Nakamura N; Hashimoto Y; Kuze T; Tasaki K; Sasaki Y; Sato M; Abe M
    Lab Invest; 1999 Aug; 79(8):925-33. PubMed ID: 10462030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
    Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
    J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 10 patients with de novo CD5 positive diffuse large B cell lymphoma].
    Zhang Q; Zhang HY; Zhong FL; Zhang WL; Xu L; Feng J; Meng QX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):399-402. PubMed ID: 23628041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CD5-positive DLBCL: molecular basis and treatment strategies].
    Miyazaki K
    Rinsho Ketsueki; 2015 Aug; 56(8):1038-44. PubMed ID: 26345564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
    Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
    Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo CD5-Positive Diffuse Large B-Cell Lymphoma: Report of a Case Presenting With Cutaneous Involvement and Featuring Extensive Intravascular Dissemination on Postmortem Examination.
    Úbeda Romero A; Santonja C; Blanco García A; Requena L; Rodríguez Pinilla SM
    Int J Surg Pathol; 2016 Dec; 24(8):763-768. PubMed ID: 27431754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.